About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [467 citations: 1–100 of 465 articles]

Articles published in Chemotherapy Research and Practice have been cited 467 times. The following is a list of the 465 articles that have cited the articles published in Chemotherapy Research and Practice.

  • Xuli Meng, Yongfeng Li, Hongchao Tang, Weimin Mao, Hongjian Yang, Xiaojia Wang, Xianfeng Ding, and Shangnao Xie, “Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer,” Amino Acids, vol. 48, no. 2, pp. 487–497, 2016. View at Publisher · View at Google Scholar
  • T. Kredo, K. Mauff, L. Workman, J. S. Van der Walt, L. Wiesner, P. J. Smith, G. Maartens, K. Cohen, and K. I. Barnes, “The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients,” Bmc Infectious Diseases, vol. 16, 2016. View at Publisher · View at Google Scholar
  • Anna G. Sorace, C. Chad Quarles, Jennifer G. Whisenant, Ariella B. Hanker, J. Oliver McIntyre, Violeta M. Sanchez, and Thomas E. Yankeelov, “Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+breast cancer: preliminary results,” Breast Cancer Research And Treatment, vol. 155, no. 2, pp. 273–284, 2016. View at Publisher · View at Google Scholar
  • Anna Klimaszewska-Wisniewska, Marta Halas-Wisniewska, Tadeusz Tadrowski, Maciej Gagat, Dariusz Grzanka, and Alina Grzanka, “Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small c,” Cancer Cell International, vol. 16, 2016. View at Publisher · View at Google Scholar
  • Quan Zhang, Tianyu Sun, Poming Kang, Kai Qian, Bo Deng, Jinghai Zhou, Ruwen Wang, Bin Jiang, Kun Li, Fang Liu, Shiyang Wu, and Qunyou Tan, “Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR i,” Cancer Chemotherapy And Pharmacology, vol. 77, no. 3, pp. 583–593, 2016. View at Publisher · View at Google Scholar
  • D. A. Fennell, Y. Summers, J. Cadranel, T. Benepal, D. C. Christoph, R. Lal, M. Das, F. Maxwell, C. Visseren-Grul, and D. Ferry, “Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer,” Cancer Treatment Reviews, vol. 44, pp. 42–50, 2016. View at Publisher · View at Google Scholar
  • Kevin Kelley, Jonathan Knisely, Marc Symons, and Rosamaria Ruggieri, “Radioresistance of Brain Tumors,” Cancers, vol. 8, no. 4, pp. 42, 2016. View at Publisher · View at Google Scholar
  • Amanda Rinkenbaugh, and Albert Baldwin, “The NF-κB Pathway and Cancer Stem Cells,” Cells, vol. 5, no. 2, pp. 16, 2016. View at Publisher · View at Google Scholar
  • Pradeepkumar L. Patel, Niki K. Rana, Mayurbhai R. Patel, Stephen D. Kozuch, and David Sabatino, “Nucleic Acid Bioconjugates in Cancer Detection and Therapy,” Chemmedchem, vol. 11, no. 3, pp. 252–269, 2016. View at Publisher · View at Google Scholar
  • T. Srikumar, M. Markow, B. Centeno, S. Hoffe, J. Tao, H. Fernandez, J. Strosberg, and D. Shibata, “Synchronous rectal adenocarcinoma and splenic marginal zone lymphoma,” Current Oncology, vol. 23, no. 1, pp. E70–E74, 2016. View at Publisher · View at Google Scholar
  • Diana R. Julie, and Karyn A. Goodman, “Advances in the Management of Anal Cancer,” Current Oncology Reports, vol. 18, no. 3, 2016. View at Publisher · View at Google Scholar
  • Wenwu Xiao, Tianhong Li, Fernanda C. Bononi, Diana Lac, Ivy A. Kekessie, Yanlei Liu, Eduardo Sanchez, Anisha Mazloom, Ai-hong Ma, Jia Lin, Jimmy Tran, Kevin Yang, Kit S. Lam, and Ruiwu Liu, “Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of alpha 3 integrin-expressing human,” Ejnmmi Research, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Caglar Yildiz, Turgut Kacan, Ozlem Bozoklu Akkar, Savas Karakus, Metin Seker, Selen Baloglu Kacan, Hatice Ozer, and Ali Cetin, “Effect of imatinib on growth of experimental endometriosis in rats,” European Journal Of Obstetrics & Gynecology And Reproductive Biology, vol. 197, pp. 159–163, 2016. View at Publisher · View at Google Scholar
  • Ok-Cheol Jeon, Dong-Hyun Seo, Han-Sung Kim, Youngro Byun, and Jin Woo Park, “Oral delivery of zoledronic acid by non-covalent conjugation with lysine-deoxycholic acid: In vitro characterization and in vivo anti-osteoporotic eff,” European Journal Of Pharmaceutical Sciences, vol. 82, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  • Seyedeh Hoda Alavizadeh, Javad Akhtari, Ali Badiee, Shiva Golmohammadzadeh, and Mahmoud Reza Jaafari, “Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models,” Expert Opinion On Drug Delivery, vol. 13, no. 3, pp. 325–336, 2016. View at Publisher · View at Google Scholar
  • Bianca K. Verlinden, Abraham Louw, and Lyn-Marie Birkholtz, “Resisting resistance: is there a solution for malaria?,” Expert Opinion On Drug Discovery, vol. 11, no. 4, pp. 395–406, 2016. View at Publisher · View at Google Scholar
  • Janella Hudson, Teresita Munoz-Antonia, Eric Haura, Doug Cress, Vani N. Simmons, and Gwendolyn P. Quinn, “Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes,” Gene, Cell and Tissue, vol. InPress, no. InPress, 2016. View at Publisher · View at Google Scholar
  • Rong Sun, Ye Zhang, Wei Zheng, Quan Tian, Ruifang An, and Yan Xue, “Clinical Characteristics of Gestational Trophoblastic Neoplasia A 15-Year Hospital-Based Study,” International Journal Of Gynecological Cancer, vol. 26, no. 1, pp. 216–221, 2016. View at Publisher · View at Google Scholar
  • Xiaofen Pan, Rui Meng, Zhonghua Yu, Jingjing Mou, Sha Liu, Ziyi Sun, Zhenwei Zou, Gang Wu, and Gang Peng, “Quinalizarin enhances radiosensitivity of nasopharyngeal carcinoma cells partially by suppressing SHP-1 expression,” International Journal Of Oncology, vol. 48, no. 3, pp. 1073–1084, 2016. View at Publisher · View at Google Scholar
  • Nikolaos Ioanou, Alan M. Sedon, Angus Dalgleish, David Mackintosh, Flavio Solca, and Helmout Modjtahedi, “Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhib,” International Journal Of Oncology, vol. 48, no. 3, pp. 908–918, 2016. View at Publisher · View at Google Scholar
  • Fengming Lan, Yang Yang, Jing Han, Qiaoli Wu, Huiming Yu, and Xiao Yue, “Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-kappa B-dependent pathway downregulating MGMT expression,” International Journal Of Oncology, vol. 48, no. 2, pp. 559–568, 2016. View at Publisher · View at Google Scholar
  • Amr S. Abu Lila, Chihiro Kato, Masakazu Fukushima, Cheng-Long Huang, Hiromi Wada, and Tatsuhiro Ishida, “Downregulation of thymidylate synthase by RNAi molecules enhances the antitumor effect of pemetrexed in an orthotopic malignant mesothelioma xenograft,” International Journal Of Oncology, vol. 48, no. 4, pp. 1399–1407, 2016. View at Publisher · View at Google Scholar
  • Vijay M. Patil, Amit Joshi, Vanita Noronha, Vibhor Sharma, Saurabh Zanwar, Sachin Dhumal, Shubhada Kane, Prathamesh Pai, Anil D’Cruz, Pankaj Chaturvedi, Atanu Bhattacharjee, and Kumar Prabhash, “Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation),” International Journal of Surgical Oncology, vol. 2016, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  • Zohreh Yousefi, Mansorhe Mottaghi, Alireza Rezaei, and Sedighe Ghasemian, “Abnormal Presentation of Choriocarcinoma and Literature Review,” Iranian Journal of Cancer Prevention, vol. InPress, no. InPress, 2016. View at Publisher · View at Google Scholar
  • Andrea Orthmann, Lisa Peiker, Iduna Fichtner, Annika Hoffmann, Ralf Axel Hilger, and Reiner Zeisig, “Improved Treatment of MT-3 Breast Cancer and Brain Metastases in a Mouse Xenograft by LRP-Targeted Oxaliplatin Liposomes,” Journal Of Biomedical Nanotechnology, vol. 12, no. 1, pp. 56–68, 2016. View at Publisher · View at Google Scholar
  • Dominik Jeschek, Gabriele Lhota, Jakob Wallner, and Karola Vorauer-Uhl, “A versatile, quantitative analytical method for pharmaceutical relevant lipids in drug delivery systems,” Journal of Pharmaceutical and Biomedical Analysis, vol. 119, pp. 37–44, 2016. View at Publisher · View at Google Scholar
  • Ye Yuan, Larry Wu, Siqi Shen, Shiyong Wu, and Monica M. Burdick, “Effect of alpha 2,6 sialylation on integrin-mediated adhesion of breast cancer cells to fibronectin and collagen IV,” Life Sciences, vol. 149, pp. 138–145, 2016. View at Publisher · View at Google Scholar
  • James P. Parker, Ziga Ude, and Celine J. Marmion, “Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer,” Metallomics, vol. 8, no. 1, pp. 43–60, 2016. View at Publisher · View at Google Scholar
  • Karina Smorodinsky-Atias, Tal Goshen-Lago, Anat Goldberg-Carp, Dganit Melamed, Alexei Shir, Navit Mooshayef, Jonah Beenstock, Yael Karamansha, Ilona Darlyuk-Saadon, Oded Livnah, Natalie G. Ahn, Arie Admon, and David Engelberg, “Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY p,” Molecular Biology Of The Cell, vol. 27, no. 6, pp. 1026–1039, 2016. View at Publisher · View at Google Scholar
  • Deng Pan, Yifan Zhu, Zhicheng Zhou, Tingting Wang, Harrison You, Changying Jiang, and Xin Lin, “The CBM Complex Underwrites NF-kappa B Activation to Promote HER2-Associated Tumor Malignancy,” Molecular Cancer Research, vol. 14, no. 1, pp. 93–102, 2016. View at Publisher · View at Google Scholar
  • Michael Ramirez, Satwik Rajaram, Robert J. Steininger, Daria Osipchuk, Maike A. Roth, Leanna S. Morinishi, Louise Evans, Weiyue Ji, Chien-Hsiang Hsu, Kevin Thurley, Shuguang Wei, Anwu Zhou, Prasad R. Koduru, Bruce A. Posner, Lani F. Wu, and Steven J. Altschuler, “Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells,” Nature Communications, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Shilpa S. Patil, Priyanka Gokulnath, Mohsin Bashir, Shivayogi D. Shwetha, Janhvi Jaiswal, Arun H. Shastry, Arivazhagan Arimappamagan, Vani Santosh, and Paturu Kondaiah, “Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and together contributes to poor patient prognosis,” Neuro-Oncology, pp. now053, 2016. View at Publisher · View at Google Scholar
  • Danielle N. Renner, Courtney S. Malo, Fang Jin, Ian F. Parney, Kevin D. Pavelko, and Aaron J. Johnson, “Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model,” Neurotherapeutics, vol. 13, no. 1, pp. 226–236, 2016. View at Publisher · View at Google Scholar
  • Weiling Sun, Chunhong Li, Meiyan Liu, Wei Liu, Chunyu Yang, and Li Cai, “Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide,” Oncology Letters, vol. 11, no. 3, pp. 2320–2326, 2016. View at Publisher · View at Google Scholar
  • Cézar da Silva Bezerra, Caio Fernando Ramalho de Oliveira, Olga Lima Tavares Machado, Gabriela Souto Vieira de Mello, Maira Galdino da Rocha Pitta, Moacyr Jesus Barreto de Melo Rêgo, Thiago Henrique Napoleão, Patrícia Maria Guedes Paiva, Suzanna de Fátima Ferreira Ribeiro, Valdirene Moreira Gomes, Osmar Nascimento Silva, Simone Maria-Neto, Octávio Luiz Franco, and Maria Lígia Rodrigues Macedo, “Exploiting the biological roles of the trypsin inhibitor from Inga vera seeds: a multifunctional Kunitz inhibitor,” Process Biochemistry, 2016. View at Publisher · View at Google Scholar
  • Aritz Retolaza, Josu Martinez-Perdiguero, Santos Merino, Marta Morales-Vidal, Pedro G. Boj, Jose A. Quintana, Jose M. Villalvilla, and Maria A. Diaz-Garcia, “Organic distributed feedback laser for label-free biosensing of ErbB2 protein biomarker,” Sensors And Actuators B-Chemical, vol. 223, pp. 261–265, 2016. View at Publisher · View at Google Scholar
  • Luis Solorio, Hanping Wu, Christopher Hernandez, Mihika Gangolli, and Agata A Exner, “ Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model ,” Therapeutic Delivery, vol. 7, no. 4, pp. 201–212, 2016. View at Publisher · View at Google Scholar
  • Ergun Karavelioglu, Mehmet Gazi Boyaci, Nejdet Simsek, Mehmet Akif Sonmez, Rabia Koc, Mustafa Karademir, Mustafa Guven, and Olcay Eser, “Selenium protects cerebral cells by cisplatin induced neurotoxicity,” Acta Cirurgica Brasileira, vol. 30, no. 6, pp. 394–400, 2015. View at Publisher · View at Google Scholar
  • Andrew W. Holle, Jennifer L. Young, and Joachim P. Spatz, “In vitro cancer cell–ECM interactions inform in vivo cancer treatment,” Advanced Drug Delivery Reviews, 2015. View at Publisher · View at Google Scholar
  • Chih-Sheng Chiang, Yi-Hsuan Tseng, Bang-Jie Liao, and San Yuan Chen, “Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy,” Advanced Healthcare Materials, 2015. View at Publisher · View at Google Scholar
  • Silvia Cervo, Elena Mansutti, Greta Del Mistro, Riccardo Spizzo, Alfonso Colombatti, Agostino Steffan, Valter Sergo, and Alois Bonifacio, “SERS analysis of serum for detection of early and locally advanced breast cancer,” Analytical and Bioanalytical Chemistry, 2015. View at Publisher · View at Google Scholar
  • Fanglei Zuo, Rui Yu, Xiujuan Feng, Lili Chen, Zhu Zeng, Gul Bahar Khaskheli, Huiqin Ma, and Shangwu Chen, “Characterization and in vitro properties of potential probiotic Bifidobacterium strains isolated from breast-fed infant feces,” Annals of Microbiology, 2015. View at Publisher · View at Google Scholar
  • S. Trivedi, F. Concha-Benavente, R. M. Srivastava, H. B. Jie, S. P. Gibson, N. C. Schmitt, and R. L. Ferris, “Immune biomarkers of anti-EGFR monoclonal antibody therapy,” Annals Of Oncology, vol. 26, no. 1, pp. 40–47, 2015. View at Publisher · View at Google Scholar
  • C. Bisschop, J. J. J. Tjalma, G. A. P. Hospers, D. Van Geldere, J. W. B. de Groot, E. M. Wiegman, M. Van't Veer-ten Kate, M. G. Havenith, J. Vecht, J. C. Beukema, G. Kats-Ugurlu, S. V. K. Mahesh, B. van Etten, K. Havenga, J. G. M. Burgerhof, D. J. A. de Groot, and W. H. de Vos Tot Nederveen Cappel, “Consequence of Restaging After Neoadjuvant Treatment for Locally Advanced Rectal Cancer,” Annals Of Surgical Oncology, vol. 22, no. 2, pp. 552–556, 2015. View at Publisher · View at Google Scholar
  • Erica Proctor, Kelley M. Kidwell, Evelyn Jiagge, Jessica Bensenhaver, Baffour Awuah, Kofi Gyan, Kathy Toy, Joseph Kwaku Oppong, Ishmael Kyei, Francis Aitpillah, Ernest Osei-Bonsu, Ernest Adjei, Michael Ohene-Yeboah, Robert Newman Brewer, Linda Ahenkorah Fondjo, Osei Owusu-Afriyie, Max Wicha, Sofia Merajver, Celina Kleer, and Lisa Newman, “Characterizing Breast Cancer in a Population with Increased Prevalence of Triple-Negative Breast Cancer: Androgen Receptor and ALDH1 Expression in Gha,” Annals Of Surgical Oncology, vol. 22, no. 12, pp. 3831–3835, 2015. View at Publisher · View at Google Scholar
  • Andrew D. Berti, Sarah L. Baines, Benjamin P. Howden, George Sakoulas, Victor Nizet, Richard A. Proctor, and Warren E. Rose, “Heterogeneity of Genetic Pathways toward Daptomycin Nonsusceptibility in Staphylococcus aureus Determined by Adjunctive Antibiotics,” Antimicrobial Agents And Chemotherapy, vol. 59, no. 5, pp. 2799–2806, 2015. View at Publisher · View at Google Scholar
  • Ebenezer Olayinka, Ayokanmi Ore, Oluwatobi Adeyemo, Olaniyi Ola, Olaoluwa Olotu, and Roseline Echebiri, “Quercetin, a Flavonoid Antioxidant, Ameliorated Procarbazine-Induced Oxidative Damage to Murine Tissues,” Antioxidants, vol. 4, no. 2, pp. 304–321, 2015. View at Publisher · View at Google Scholar
  • Hyun Jung Kim, Aeree Kim, Hyeongsik Ahn, Il Min Ahn, Jinhyuk Choi, and Hyeyoon Chang, “Meta-analysis reveals no significant correlation between breast cancer survival and ErbB3 expression,” Apmis, vol. 123, no. 5, pp. 383–393, 2015. View at Publisher · View at Google Scholar
  • G. Jaimee, and P. M. Halami, “Emerging resistance to aminoglycosides in lactic acid bacteria of food origin—an impending menace,” Applied Microbiology and Biotechnology, 2015. View at Publisher · View at Google Scholar
  • Damoun Safarpour, and Fattaneh A. Tavassoli, “A Targetable Androgen Receptor–Positive Breast Cancer Subtype Hidden Among the Triple-Negative Cancers,” Archives of Pathology & Laboratory Medicine, vol. 139, no. 5, pp. 612–617, 2015. View at Publisher · View at Google Scholar
  • Davood Mahdian, Milad Iranshahy, Abolfazl Shakeri, Azar Hoseini, Hoda Yavari, Melika Nazemi, and Mehrdad Iranshahi, “Cytotoxicity evaluation of extracts and fractions of five marine sponges from the Persian Gulf and HPLC fingerprint analysis of cytotoxic extracts,” Asian Pacific Journal of Tropical Biomedicine, 2015. View at Publisher · View at Google Scholar
  • Junqi Liu, Di Zhao, and Ruitai Fan, “Shared and unique mutational gene co-occurrences in cancers,” Biochemical and Biophysical Research Communications, 2015. View at Publisher · View at Google Scholar
  • Takashi Hoshiba, and Masaru Tanaka, “Optimization of the tissue source, malignancy, and initial substrate of tumor cell-derived matrices to increase cancer cell chemoresistance against 5-fluorouracil,” Biochemical and Biophysical Research Communications, 2015. View at Publisher · View at Google Scholar
  • Yen-Hao Su, Wan-Chun Tang, Ya-Wen Cheng, Peik Sia, Chi-Chen Huang, Yi-Chao Lee, Hsin-Yi Jiang, Ming-Heng Wu, I-Lu Lai, Jun-Wei Lee, and Kuen-Haur Lee, “Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer,” Biochimica Et Biophysica Acta-Molecular Cell Research, vol. 1853, no. 10, pp. 2261–2272, 2015. View at Publisher · View at Google Scholar
  • Andrea Ravalli, Carolina Gomes da Rocha, Hideko Yamanaka, and Giovanna Marrazza, “A label-free electrochemical affisensor for cancer marker detection: The case of HER2,” Bioelectrochemistry, 2015. View at Publisher · View at Google Scholar
  • Amit Frishberg, Yael Steuerman, and Irit Gat-Viks, “CoD: inferring immune-cell quantities related to disease states,” Bioinformatics, vol. 31, no. 24, pp. 3961–3969, 2015. View at Publisher · View at Google Scholar
  • Carlos A. López-Morales, Mariana P. Miranda-Hernández, L. Carmina Juárez-Bayardo, Nancy D. Ramírez-Ibáñez, Alexis J. Romero-Díaz, Nelly Piña-Lara, Víctor R. Campos-García, Néstor O. Pérez, Luis F. Flores-Ortiz, and Emilio Medina-Rivero, “Physicochemical and Biological Characterization of a Biosimilar Trastuzumab,” BioMed Research International, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Mariana P. Miranda-Hernández, Carlos A. López-Morales, Nelly Piña-Lara, Francisco C. Perdomo-Abúndez, Néstor O. Pérez, Jorge Revilla-Beltri, Aarón Molina-Pérez, Larisa Estrada-Marín, Luis F. Flores-Ortiz, Alejandro Ruiz-Argüelles, and Emilio Medina-Rivero, “Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization,” BioMed Research International, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Anna Shivinsky, Tomer Bronshtein, Tom Haber, and Marcelle Machluf, “The effect of AZD2171-or sTRAIL/Apo2L-loaded polylactic-co-glycolic acid microspheres on a subcutaneous glioblastoma model,” Biomedical Microdevices, vol. 17, no. 4, 2015. View at Publisher · View at Google Scholar
  • Kai-Jie Kao, Chien-Hsuan Tai, Wen-Hsin Chang, Ta-Sen Yeh, Tse-Ching Chen, and Gwo-Bin Lee, “A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells,” Biosensors and Bioelectronics, vol. 69, pp. 272–279, 2015. View at Publisher · View at Google Scholar
  • Silviya Petrova Zustiak, Smritee Dadhwal, Carlos Medina, Sonette Steczina, Yasaman Chehreghanianzabi, Anisa Ashraf, and Prashanth Asuri, “Three-dimensional matrix stiffness and adhesive ligands affect cancer cell response to toxins,” Biotechnology and Bioengineering, 2015. View at Publisher · View at Google Scholar
  • Xiaodan Cao, Haijun Yu, Chao Chen, Jia Wei, and Ping Wang, “Expression and characterization of recombinant humanized anti-HER2 single-chain antibody in Pichia pastoris for targeted cancer therapy,” Biotechnology Letters, vol. 37, no. 7, pp. 1347–1354, 2015. View at Publisher · View at Google Scholar
  • Gerwyn Morris, Michael Berk, Ken Walder, and Michael Maes, “Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses,” BMC Medicine, vol. 13, no. 1, 2015. View at Publisher · View at Google Scholar
  • Kristian Barlinn, Hans Lehrach, Timo Siepmann, David Braeuer, Ulrich Buntrock, and Norbert Sassim, “Temporary loss of moral behavior in a patient undergoing chemotherapy with cisplatin - breaking bad,” Bmc Psychiatry, vol. 15, 2015. View at Publisher · View at Google Scholar
  • Soudabeh Sabetian, and Mohd Shahir Shamsir, “Identification of putative drug targets for human sperm-egg interaction defect using protein network approach,” Bmc Systems Biology, vol. 9, 2015. View at Publisher · View at Google Scholar
  • David Balayssac, Jeremy Ferrier, Bruno Pereira, Brigitte Gillet, Caroline Petorin, Julie Vein, Frederic Libert, Alain Eschalier, and Denis Pezet, “Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, sin,” Bmj Open, vol. 5, no. 4, 2015. View at Publisher · View at Google Scholar
  • Takahisa Imamura, Mutsuko Yamamoto-Ibusuki, Aiko Sueta, Tatsuko Kubo, Atsushi Irie, Ken Kikuchi, Toru Kariu, and Hirotaka Iwase, “Influence of the C5a–C5a receptor system on breast cancer progression and patient prognosis,” Breast Cancer, 2015. View at Publisher · View at Google Scholar
  • Callie R. Merry, Sarah McMahon, Cheryl L. Thompson, Kristy L. S. Miskimen, Lyndsay N. Harris, and Ahmad M. Khalil, “Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+breast cancer,” Breast Cancer Research And Treatment, vol. 150, no. 2, pp. 321–334, 2015. View at Publisher · View at Google Scholar
  • Amelie Schramm, Nikolaus De Gregorio, Peter Widschwendter, Visnja Fink, and Jens Huober, “Targeted Therapies in HER2-Positive Breast Cancer - a Systematic Review,” Breast Care, vol. 10, no. 3, pp. 173–178, 2015. View at Publisher · View at Google Scholar
  • Khalid O Alfarouk, Christian-Martin Stock, Sophie Taylor, Megan Walsh, Abdel Khalig Muddathir, Daniel Verduzco, Adil H H Bashir, Osama Y Mohammed, Gamal O Elhassan, Salvador Harguindey, Stephan J Reshkin, Muntaser E Ibrahim, and Cyril Rauch, “Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp,” Cancer Cell International, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar
  • Ivy Paw, Richard C. Carpenter, Kounosuke Watabe, Waldemar Debinski, and Hui-Wen Lo, “Mechanisms regulating glioma invasion,” Cancer Letters, vol. 362, no. 1, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Miao Wang, Mary Topalovski, Jason E. Toombs, Christopher M. Wright, Zachary R. Moore, David A. Boothman, Hiromi Yanagisawa, Huamin Wang, Agnieszka Witkiewicz, Diego H. Castrillon, and Rolf A. Brekken, “Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer,” Cancer Research, vol. 75, no. 23, pp. 5058–5069, 2015. View at Publisher · View at Google Scholar
  • É. Le Rhun, C. Mateus, L. Mortier, F. Dhermain, B. Guillot, J.-J. Grob, C. Lebbe, M. Thomas, T. Jouary, M.-T. Leccia, and C. Robert, “Traitement systémique des métastases cérébrales de mélanome,” Cancer/Radiothérapie, 2015. View at Publisher · View at Google Scholar
  • Mireia Nager, Maria Santacana, Deepshikha Bhardwaj, Joan Valls, Isidre Ferrer, Pere Nogues, Carles Canti, and Judit Herreros, “Nuclear phosphorylated Y142 beta-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion,” Cell Cycle, vol. 14, no. 22, pp. 3644–3655, 2015. View at Publisher · View at Google Scholar
  • Yanan Tang, Zhixin Wang, Xiaolong Yang, Junbo Chen, Linan Liu, Weian Zhao, X. Chris Le, and Feng Li, “Constructing real-time, wash-free, and reiterative sensors for cell surface proteins using binding-induced dynamic DNA assembly,” Chemical Science, vol. 6, no. 10, pp. 5729–5733, 2015. View at Publisher · View at Google Scholar
  • Richard J. Albertini, Elizabeth W. Carter, Janice A. Nicklas, Pamela M. Vacek, and Vernon E. Walker, “1,3-Butadiene, CML and the t(9:22) translocation: A reality check,” Chemico-Biological Interactions, 2015. View at Publisher · View at Google Scholar
  • Jian-Wei Zhang, Tao Qin, Shao-Dong Hong, Jing Zhang, Wen-Feng Fang, Yuan-Yuan Zhao, Yun-Peng Yang, Cong Xue, Yan Huang, Hong-Yuan Zhao, Yu-Xiang Ma, Zhi-Huang Hu, Pei-Yu Huang, and Li Zhang, “Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma,” Chinese Journal Of Cancer, vol. 34, 2015. View at Publisher · View at Google Scholar
  • Xiao-Yun Hu, Ji-Yun Liang, Xue-Jun Guo, Li Liu, and Ya-Bing Guo, “5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (Delta Psi m)-mediated apoptosis in hepato,” Clinical And Experimental Pharmacology And Physiology, vol. 42, no. 2, pp. 146–153, 2015. View at Publisher · View at Google Scholar
  • Weining Hu, and Yu Huang, “Targeting the platelet-derived growth factor signalling in cardiovascular disease,” Clinical and Experimental Pharmacology and Physiology, vol. 42, no. 12, pp. 1221–1224, 2015. View at Publisher · View at Google Scholar
  • Marissa D. Friedman, Mario Lacouture, and Chau Dang, “Dermatologic Adverse Events Associated with use of Adjuvant Lapatinib in Combination with Paclitaxel and Trastuzumab for HER2 positive Breast Cancer: A Case Series Analysis,” Clinical Breast Cancer, 2015. View at Publisher · View at Google Scholar
  • Bin-Chi Liao, Yu-Yun Shao, Ho-Min Chen, Wen-Yi Shau, Zhong-Zhe Lin, Raymond Nienchen Kuo, Chiu-Ling Lai, Kuo-Hsing Chen, Ann-Lii Cheng, James Chih-Hsin Yang, and Mei-Shu Lai, “Comparative Effectiveness of First-Line Platinum-Based Chemotherapy Regimens for Advanced Lung Squamous Cell Carcinoma,” Clinical Lung Cancer, vol. 16, no. 2, pp. 137–143, 2015. View at Publisher · View at Google Scholar
  • Mahino Fatima, Nazura Usmani, Faldha Firdaus, Mohammad Faraz Zafeer, Shafeeque Ahmad, Kafil Akhtar, S. M. Dawar Husain, Mir Hilal Ahmad, Ehraz Anis, and M. Mobarak Hossain, “In vivo induction of antioxidant response and oxidative stress associated with genotoxicity and histopathological alteration in two commercial fish sp,” Comparative Biochemistry And Physiology C-Toxicology & Pharmacology, vol. 176, pp. 17–30, 2015. View at Publisher · View at Google Scholar
  • Wolfgang Marx, Karin Ried, Alexandra L McCarthy, Luis Vitetta, Avni Sali, Daniel McKavanagh, and Elisabeth Isenring, “Ginger—Mechanism of Action in Chemotherapy-induced Nausea and Vomiting: A Review,” Critical Reviews in Food Science and Nutrition, pp. 00–00, 2015. View at Publisher · View at Google Scholar
  • Christopher G. England, Chin F. Ng, Victor van Berkel, and Hermann B. Frieboes, “A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity,” Current Drug Targets, vol. 16, no. 10, pp. 1057–1087, 2015. View at Publisher · View at Google Scholar
  • Guido Cavaletti, and Paola Marmiroli, “Chemotherapy-induced peripheral neurotoxicity,” Current Opinion in Neurology, vol. 28, no. 5, pp. 500–507, 2015. View at Publisher · View at Google Scholar
  • Anatolii Romaniuk, and Mykola Lyndin, “Immune microenvironment as a factor of breast cancer progression,” Diagnostic Pathology, vol. 10, 2015. View at Publisher · View at Google Scholar
  • Geng Guo, Cheng-liang Zhong, Yang Liu, Xing-gang Mao, Zheng Zhang, Ji Jin, Jing Liu, Liu Yang, Jin-ming Mao, Yu-hong Guo, and Yuan-li Zhao, “Overexpression of FRAT1 Is Associated with Malignant Phenotype and Poor Prognosis in Human Gliomas,” Disease Markers, vol. 2015, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Mohammad Waseem, Monica Bhardwaj, Heena Tabassum, Sheikh Raisuddin, and Suhel Parvez, “Cisplatin hepatotoxicity mediated by mitochondrial stress,” Drug and Chemical Toxicology, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Raphael Tavares, Nicole M. Scherer, Carlos G. Ferreira, Fabricio F. Costa, and Fabio Passetti, “Splice variants in the proteome: a promising and challenging field to targeted drug discovery,” Drug Discovery Today, vol. 20, no. 3, pp. 353–360, 2015. View at Publisher · View at Google Scholar
  • J. Gras, “ABITUZUMAB Anti-Integrin alpha(nu) (CD51, ITGAV) MAb, Oncolytic,” Drugs Of The Future, vol. 40, no. 2, pp. 97–100, 2015. View at Publisher · View at Google Scholar
  • Sree Harsha, Bandar E. Al-Dhubiab, Anroop B. Nair, Mohammed Al-Khars, Mohammed Al-Hassan, Raja Rajan, Mahesh Attimarad, Katharigatta N. Venugopala, and Afzal Haq Asif, “Novel Drying Technology of Microsphere and Its Evaluation for Targeted Drug Delivery for Lungs,” Drying Technology, vol. 33, no. 4, pp. 502–512, 2015. View at Publisher · View at Google Scholar
  • N. van der Linden, C. W. M. van Gils, C. P. Pescott, J. Buter, M. R. Vergeer, and C. A. Uyl-de Groot, “Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck,” European Archives Of Oto-Rhino-Laryngology, vol. 272, no. 8, pp. 2007–2016, 2015. View at Publisher · View at Google Scholar
  • Manu M. Joseph, S.R. Aravind, Suraj K. George, K. Raveendran Pillai, S. Mini, and T.T. Sreelekha, “Anticancer activity of galactoxyloglucan polysaccharide–conjugated doxorubicin nanoparticles: mechanistic insights and interactome analysis,” European Journal of Pharmaceutics and Biopharmaceutics, 2015. View at Publisher · View at Google Scholar
  • Pamela Ovadje, Alessia Roma, Matthew Steckle, Leah Nicoletti, John Thor Arnason, and Siyaram Pandey, “Advances in the Research and Development of Natural Health Products as Main Stream Cancer Therapeutics,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Giovanni Sortino, Francesco Passiglia, Sergio Rizzo, Francesca Lo Vullo, Antonio Galvano, Viviana Bazan, Christian Rolfo, Antonio Russo, and Giuseppe Bronte, “Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario,” Expert Opinion On Biological Therapy, vol. 15, no. 1, pp. 45–59, 2015. View at Publisher · View at Google Scholar
  • Laura Poupon, Nicolas Kerckhove, Julie Vein, Sylvain Lamoine, Nicolas Authier, Jerome Busserolles, and David Balayssac, “Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives,” Expert Opinion On Drug Safety, vol. 14, no. 8, pp. 1269–1282, 2015. View at Publisher · View at Google Scholar
  • Hani J. Alturkmani, Ziyan Y. Pessetto, and Andrew K. Godwin, “Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor,” Expert Opinion On Investigational Drugs, vol. 24, no. 8, pp. 1045–1058, 2015. View at Publisher · View at Google Scholar
  • Fiona Taylor, and Barry W. Hancock, “Pharmacotherapy of placental site and epithelioid trophoblastic tumours,” Expert Opinion On Orphan Drugs, vol. 3, no. 1, pp. 75–85, 2015. View at Publisher · View at Google Scholar
  • Rosalba D'Alessandro, Caterina Messa, Maria Grazia Refolo, and Brian I. Carr, “Modulation of sensitivity and resistance tomultikinase inhibitors by microenvironmental platelet factors in HCC,” Expert Opinion On Pharmacotherapy, vol. 16, no. 18, pp. 2773–2780, 2015. View at Publisher · View at Google Scholar
  • Francesca Musumeci, Silvia Schenone, Giancarlo Grossi, Chiara Brullo, and Monica Sanna, “Analogs, formulations and derivatives of imatinib: a patent review,” Expert Opinion On Therapeutic Patents, vol. 25, no. 12, pp. 1411–1421, 2015. View at Publisher · View at Google Scholar